4398 |
Adherence Terminology & Program Updates |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4399 |
Adherence Quality Indicators |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4405 |
Adherence Monitoring Methods - Manual |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4411 |
Patient Escalations |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4408 |
Selection of Monitoring Methods by Type of Digital Technology |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4407 |
Selection of Monitoring Methods by Type of Patient |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4413 |
Adherence Intervention |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4472 |
Presumptive TB Examination Rate |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4486 |
Community based death review |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4487 |
Facility-based mortality audit [FBMA] |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4510 |
Limit concept |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4566 |
Monitoring indicators for case finding |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4567 |
Monitoring indicators related to Notification |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4568 |
Monitoring indicators related to UDST |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4569 |
Monitoring indicators related to ACF |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4727 |
Community-Based Assessment Checklist [CBAC] Form for Early Detection of NCDs and Tuberculosis |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4803 |
Monitoring indicators related to TB Treatment |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4804 |
Monitoring indicators related to DR-TB Treatment |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4807 |
Monitoring indicator for TB Treatment outcome |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4809 |
Monitoring indicators related to Adherence |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4811 |
Monitoring of indicators related to TB-HIV |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4813 |
Monitoring of indicators related to TB-HIV Treatment |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4815 |
Monitoring of indicators related to TB-HIV prevention |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4817 |
Monitoring of Tobacco usage in TB patients |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4819 |
Monitoring of indicators related to DBT |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4834 |
General Process of Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4835 |
Pre-requisites for Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4836 |
Planning for Supervisory visit |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4837 |
Guidelines for Selection of area/health facility for Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4838 |
Modalities of Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |